Tetrodotoxin (TTX) as a therapeutic agent for pain

Marine Drugs

Volumn 10, Issue 2, 2012, Pages 281-305

  Nieto, Francisco Rafael ^a   Cobos, Enrique José ^a   Tejada, Miguel Ángel ^a   Sánchez Fernández, Cristina ^a   González Cano, Rafael ^a   Cendán, Cruz Miguel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Neuropathic pain; Pain; Tetrodotoxin; TTX; TTX sensitive voltage gated sodium channels

Indexed keywords

BUPIVACAINE; CARBAMAZEPINE; LIDOCAINE; SODIUM CHANNEL NAV1.1; SODIUM CHANNEL NAV1.2; SODIUM CHANNEL NAV1.3; SODIUM CHANNEL NAV1.4; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.6; SODIUM CHANNEL NAV1.7; TETRODOTOXIN; TRICYCLIC ANTIDEPRESSANT AGENT; VOLTAGE GATED SODIUM CHANNEL;

ANALGESIC ACTIVITY; ANTINOCICEPTION; CHANNEL GATING; CHRONIC PAIN; DOWN REGULATION; DRUG ADMINISTRATION ROUTE; DRUG DETERMINATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG TARGETING; HYPERALGESIA; INFLAMMATION; INFLAMMATORY DISEASE; INFLAMMATORY PAIN; NERVE BLOCK; NERVE CELL MEMBRANE CONDUCTANCE; NEUROMA; NEUROPATHIC PAIN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STIMULUS RESPONSE; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 84858241693     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md10020281     Document Type: Review

References (129)

1. Woolf, C.J. What is this thing called pain? J. Clin. Invest. 2010, 120, 3742-3744.
2. Goldberg, D.S.; McGee, S.J. Pain as a global public health priority. BMC Public Health 2011, 11, doi:10.1186/1471-2458-11-770.
3. Narahashi, T. Tetrodotoxin: A brief history. Proc. Jpn. Acad. Ser. B 2008, 84, 147-154.
4. Dib-Hajj, S.D.; Cummins, T.R.; Black, J.A.; Waxman, S.G. Sodium channels in normal and pathological pain. Annu. Rev. Neurosci. 2010, 33, 325-347.
5. Catterall, W.A. From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels. Neuron 2000, 26, 13-25.
6. Yu, F.H.; Catterall, W.A. Overview of the voltage-gated sodium channel family. Genome Biol. 2003, 4, doi:10.1186/gb-2003-4-3-207.
7. Chahine, M.; O'Leary, M.E. Regulatory role of voltage-gated Na channel β Subunits in sensory neurons. Front. Pharmacol. 2011, 2,doi:10.3389/fphar. 2011.00070.
8. Catterall, W.A.; Goldin, A.L.; Waxman, S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005, 57, 397-409. (Pubitemid 43036431)
9. Ulbricht, W. Sodium channel inactivation: Molecular determinants and modulation. Physiol. Rev. 2005, 85, 1271-1301. (Pubitemid 41362271)
10. Ragsdale, D.S., McPhee, J.C.; Scheuer, T.; Catterall, W.A. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc. Natl. Acad. Sci. USA 1996, 93, 9270-9275. (Pubitemid 26282053)
11. Catterall, W.A.; Cestèle, S.; Yarov-Yarovoy, V.; Yu, F.H.; Konoki, K.; Scheuer, T. Voltage-gated ion channels and gating modifier toxins. Toxicon 2007, 49, 124-141. (Pubitemid 46151715)
12. Fozzard, H.A.; Lipkind, G.M. The tetrodotoxin binding site is within the outer vestibule of the sodium channel. Mar. Drugs 2010, 8, 219-234.
13. Lee, C.H.; Ruben, P.C. Interaction between voltage-gated sodium channels and the neurotoxin, tetrodotoxin. Channels 2008, 2, 407-412.
14. Geffeney, S.L.; Ruben, P.C. The structural basis and functional consequences of interactions between tetrodotoxin and voltage-gated sodium channels. Mar. Drugs 2006, 4, 143-156. (Pubitemid 43763910)
15. Black, J.A.; Waxman, S.G. Sodium channel expression: A dynamic process in neurons and non-neuronal cells. Dev. Neurosci. 1996, 18, 139-152. (Pubitemid 26317168)
16. Black, J.A.; Waxman, S.G. Sodium channels and microglial function. Exp. Neurol. 2011, (in press).
17. Verkhratsky, A.; Steinhäuser, C. Ion channels in glial cells. Brain Res. Rev. 2000, 32, 380-412. (Pubitemid 30171314)
18. Sontheimer, H.; Waxman, S.G. Ion channels in spinal cord astrocytes in vitro: II. Biophysical and pharmacological analysis of two Na+ current types. J. Neurophysiol. 1992, 68, 1001-1011.
19. Sontheimer, H.; Fernandez-Marques, E.; Ullrich, N.; Pappas, C.; Waxman, S.G. Astrocyte Na+ channels are required for maintenance of Na+/K+-ATPase activity. J. Neurosci. 1994, 14, 2464-2475 (Pubitemid 24140878)
20. Amin, A.S.; Asghari-Roodsari, A.; Tan, H.L. Cardiac sodium channelopathies. Pflugers Arch. 2010, 460, 223-237.
21. Cox, J.J.; Reimann, F.; Nicholas, A.K.; Thornton, G.; Roberts, E.; Springell, K.; Karbani, G.; Jafri, H.; Mannan, J.; Raashid, Y.; et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006, 444, 894-898.
22. Shi, X.; Yasumoto, S.; Kurahashi, H.; Nakagawa, E.; Fukasawa, T.; Uchiya, S.; Hirose, S. Clinical spectrum of SCN2A mutations. Brain Dev. 2011, in press.
23. Venance, S.L.; Cannon, S.C.; Fialho, D.; Fontaine, B.; Hanna, M.G.; Ptacek, L.J.; Tristani-Firouzi, M.; Tawil, R.; Griggs, R.C.; CINCH investigators. The primary periodic paralyses: Diagnosis, pathogenesis and treatment. Brain 2006, 129, 8-17.
24. Waxman, S.G. Transcriptional channelopathies: An emerging class of disorders. Nat. Rev. Neurosci. 2006, 2, 652-659.
25. Liu, M.; Wood, J.N. The roles of sodium channels in nociception: Implications for mechanisms of neuropathic pain. Pain Med. 2011, 12, S93-S99.
26. Bhattacharya, A.; Wickenden, A.D.; Chaplan, S.R. Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics 2009, 6, 663-678.
27. Dib-Hajj, S.D.; Black, J.A.; Waxman, S.G. Voltage-gated sodium channels: Therapeutic targets for pain. Pain Med. 2009, 10, 1260-1269.
28. Waxman, S.G.; Kocsis, J.D.; Black, J.A. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J. Neurophysiol. 1994, 72, 466-470. (Pubitemid 24233666)
29. Dib-Hajj, S.D.; Black, J.A.; Felts, P.; Waxman, S.G. Down-regulation of transcripts for Na channel alpha-SNS in spinal sensory neurons following axotomy. Proc. Natl. Acad. Sci. USA 1996, 93, 14950-14954. (Pubitemid 26419076)
30. Dib-Hajj, S.D.; Tyrrell, L.; Black, J.A.; Waxman, S.G. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. Proc. Natl. Acad. Sci. USA 1998, 95, 8963-8968. (Pubitemid 28350597)
31. Dib-Hajj, S.D.; Fjell, J.; Cummins, T.R.; Zheng, Z.; Fried, K.; LaMotte, R.; Black, J.A.; Waxman, S.G. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 1999, 83, 591-600.
32. Kim, C.H.; Oh, Y.; Chung, J.M.; Chung, K. The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. Brain Res. Mol. Brain Res. 2001, 95, 153-161. (Pubitemid 33000374)
33. Rizzo, M.A.; Kocsis, J.D.; Waxman, S.G. Selective loss of slow and enhancement of fast Na+ currents in cutaneous afferent dorsal root ganglion neurones following axotomy. Neurobiol. Dis. 1995, 2, 87-96.
34. Cummins, T.R.; Waxman, S.G. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J. Neurosci. 1997, 17, 3503-3514. (Pubitemid 27200579)
35. Black, J.A.; Cummins, T.R.; Plumpton, C.; Chen, Y.H.; Hormuzdiar, W.; Clare, J.J.; Waxman, S.G. Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J. Neurophysiol. 1999, 82, 2776-2785.
36. Rush, A.M.; Cummins, T.R.; Waxman, S.G. Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J. Physiol. 2007, 579, 1-14.
37. Trimmer, J.S.; Cooperman, S.S.; Tomiko, S.A.; Zhou, J.; Crean, S.M.; Boyle, M.B.; Kalen, R.G.; Sheng, Z.; Barchi, R.L.; Sigworth, F.J.; et al. Primary structure and functional expression of a mammalian skeletal muscle sodium channel. Neuron 1989, 3, 33-49.
38. Black, J.A.; Dib-Hajj, S.; McNabola, K.; Jeste, S.; Rizzo, M.A.; Kocsis, J.D.; Waxman, S.G. Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. Brain Res. Mol. Brain Res. 1996, 43, 117-131. (Pubitemid 27042398)
39. Fukuoka, T.; Kobayashi, K.; Yamanaka, H.; Obata, K.; Dai, Y.; Noguchi, K. Comparative study of the distribution of the alpha-subunits of voltage-gated sodium channels in normal and axotomized rat dorsal root ganglion neurons. J. Comp. Neurol. 2008, 5, 188-206.
40. Costigan M.; Scholz J.; Woolf, C.J. Neuropathic pain: A maladaptive response of the nervous system to damage. Annu. Rev. Neurosci. 2009, 32, 1-32.
41. Dichgans, M.; Freilinger, T.; Eckstein, G.; Babini, E.; Lorenz-Depiereux, B.; Biskup, S.; Ferrari, M.D.; Herzog, J.; van den Maagdenberg, A.M.; Pusch, M.; Strom, T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366, 371-377. (Pubitemid 41073954)
42. Black, J.A.; Nikolajsen, L.; Kroner, K.; Jensen, T.S.; Waxman, S.G. Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann. Neurol. 2008, 64, 644-653.
43. Black, J.A.; Liu, S.; Tanaka, M.; Cummins, T.R.; Waxman, S.G. Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 2004, 108, 237-247. (Pubitemid 38353046)
44. Zhao, P.; Waxman, S.G.; Hains, B.C. Sodium channel expression in the ventral posterolateral nucleus of the thalamus after peripheral nerve injury. Mol. Pain 2006, 2, doi:10.1186/1744-8069-2-27.
45. Berta, T.; Poirot, O.; Pertin, M.; Ji, R.R.; Kellenberger, S.; Decosterd, I. Transcriptional and functional profiles of voltage-gated Na(+) channels in injured and non-injured DRG neurons in the SNI model of neuropathic pain. Mol. Cell. Neurosci. 2008, 37, 196-208. (Pubitemid 351173844)
46. Wang, W.; Atianjoh, F.; Gauda, E.B.; Yaster, M.; Li, Y.; Tao, Y.X. Increased expression of sodium channel subunit Nav1.1 in the injured dorsal root ganglion after peripheral nerve injury. Anat. Rec. (Hoboken) 2011, 294, 1406-1411.
47. Vacher, H.; Mohapatra, D.P.; Trimmer, J.S. Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol. Rev. 2008, 88, 1407-1447.
48. Hildebrand, M.E.; Mezeyova, J.; Smith, P.L.; Salter, M.W.; Tringham, E.; Snutch, T.P. Identification of sodium channel isoforms that mediate action potential firing in lamina I/II spinal cord neurons. Mol. Pain 2011, 7, doi:10.1186/1744-8069-7-67.
49. Lindia, J.A.; Abbadie, C. Distribution of the voltage gated sodium channel Na(v)1.3-like immunoreactivity in the adult rat central nervous system. Brain Res. 2003, 960, 132-141. (Pubitemid 36044569)
50. Fukuoka, T.; Kobayashi, K.; Noguchi, K. Laminae-specific distribution of alpha-subunits of voltage-gated sodium channels in the adult rat spinal cord. Neuroscience 2010, 169, 994-1006.
51. Coward, K.; Aitken, A.; Powell, A.; Plumpton, C.; Birch, R.; Tate, S.; Bountra, C.; Anand, P. Plasticity of TTX-sensitive sodium channels PN1 and brain III in injured human nerves. Neuroreport 2001, 12, 495-500. (Pubitemid 32173954)
52. Siqueira, S.R.; Alves, B.; Malpartida, H.M.; Teixeira, M.J.; Siqueira, J.T. Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia. Neuroscience 2009, 164, 573-577.
53. Abe, M.; Kurihara, T.; Han, W.; Shinomiya, K; Tanabe, T. Changes in expression of voltage-dependent ion channel subunits in dorsal root ganglia of rats with radicular injury and pain. Spine 2002, 27, 1517-1524. (Pubitemid 34787175)
54. Craner, M.J.; Klein, J.P.; Renganathan, M.; Black, J.A.; Waxman, S.G. Changes of sodium channel expression in experimental painful diabetic neuropathy. Ann. Neurol. 2002, 52, 786-792. (Pubitemid 35403189)
55. Wallace, V.C.; Cottrell, D.F.; Brophy, P.J.; Fleetwood-Walker, S.M. Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids. J. Neurosci. 2003, 23, 3221-3233. (Pubitemid 36531963)
56. Hong, S.; Morrow, T.J.; Paulson, P.E.; Isom, L.L.; Wiley, J.W. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 2004, 279, 29341-29350. (Pubitemid 38915812)
57. Shah, B.S.; Rush, A.M.; Liu, S.; Tyrrell, L.; Black, J.A.; Dib-Hajj, S.D.; Waxman, S.G. Contactin associates with sodium channel Nav1.3 in native tissues and increases channel density at the cell surface. J. Neurosci. 2004, 24, 7387-7399. (Pubitemid 39100707)
58. Garry, E.M.; Delaney, A.; Anderson, H.A.; Sirinathsinghji, E.C.; Clapp, R.H.; Martin, W.J.; Kinchington, P.R.; Krah, D.L.; Abbadie, C.; Fleetwood-Walker, S.M. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 2005, 118, 97-111. (Pubitemid 41566589)
59. Lindia, J.A.; Köhler, M.G.; Martin, W.J.; Abbadie, C. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Pain 2005, 117, 145-153. (Pubitemid 41764782)
60. He, X.H.; Zang, Y.; Chen, X.; Pang, R.P.; Xu, J.T.; Zhou, X.; Wei, X.H.; Li, Y.Y.; Xin, W.J.; Qin, Z.H.; Liu, X.G. TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury. Pain 2010, 151, 266-279.
61. Zhang, Y.; Guzinski, M.; Eger, E.I., 2nd.; Laster, M.J.; Sharma, M.; Harris, R.A.; Hemmings, H.C., Jr. Bidirectional modulation of isoflurane potency by intrathecal tetrodotoxin and veratridine in rats. Br. J. Pharmacol. 2010, 159, 872-878.
62. Cheng, K.I.; Lai, C.S.; Wang, F.Y.; Wang, H.C.; Chang, L.L.; Ho, S.T.; Tsai, H.P.; Kwan, A.L. Intrathecal lidocaine pretreatment attenuates immediate neuropathic pain by modulating Nav1.3 expression and decreasing spinal microglial activation. BMC Neurol. 2011, 11, doi:10.1186/1471-2377-11-71.
63. Mo, G.; Grant, R.; O'Donnell, D.; Ragsdale, D.S.; Cao, C.Q.; Séguéla, P. Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C. Mol. Pain 2011, 7, doi:10.1186/1744-8069-7-14.
64. Fukuoka, T.; Yamanaka, H.; Kobayashi, K.; Okubo, M.; Miyoshi, K.; Dai, Y.; Noguchi, K. Re-evaluation of the phenotypic changes in L4 dorsal root ganglion neurons after L5 spinal nerve ligation. Pain 2012, 153, 68-79.
65. Eriksson, J.; Jablonski, A.; Persson, A.K.; Hao, J.X.; Kouya, P.F.; Wiesenfeld-Hallin, Z.; Xu, X.J.; Fried, K. Behavioral changes and trigeminal ganglion sodium channel regulation in an orofacial neuropathicpain model. Pain 2005, 119, 82-94. (Pubitemid 41752968)
66. Hains, B.C.; Klein, J.P.; Saab, C.Y.; Craner, M.J.; Black, J.A.; Waxman, S.G. Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J. Neurosci. 2003, 23, 8881-8892. (Pubitemid 37210901)
67. Hains, B.C.; Saab, C.Y.; Klein, J.P.; Craner, M.J.; Waxman, S.G. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J. Neurosci. 2004, 24, 4832-4839. (Pubitemid 38668207)
68. Hains, B.C.; Saab, C.Y.; Waxman, S.G. Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury. Brain 2005, 128, 2359-2371. (Pubitemid 41407975)
69. Xiao, H.S.; Huang, Q.H.; Zhang, F.X.; Bao, L.; Lu, Y.J.; Guo, C.; Yang, L.; Huang, W.J.; Fu, G.; Xu, S.H.; et al. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc. Natl. Acad. Sci. USA 2002, 99, 8360-8365.
70. Cummins, T.R.; Aglieco, F.; Renganathan, M.; Herzog, R.I.; Dib-Hajj, S.D.; Waxman, S.G. Nav1.3 sodium channels: Rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J. Neurosci. 2001, 21, 5952-5961. (Pubitemid 32737728)
71. Lampert, A.; Hains, B.C.; Waxman, S.G. Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury. Exp. Brain Res. 2006, 174, 660-666. (Pubitemid 44497438)
72. Huang, H.L.; Cendan, C.M.; Roza, C.; Okuse, K.; Cramer, R.; Timms, J.F.; Wood, J.N. Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves. Mol. Pain 2008, 4, doi:10.1186/1744-8069-4-33.
73. Thakor, D.K.; Lin, A.; Matsuka, Y.; Meyer, E.M.; Ruangsri, S.; Nishimura, I.; Spigelman, I. Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painfulneuropathy. Mol. Pain 2009, 5, doi:10.1186/1744-8069-5- 14.
74. Ohno, K.; Yokota, A.; Hirofuji, S.; Kanbara, K.; Ohtsuka, H.; Kinoshita, M. Altered expression of sodium channel distribution in the dorsal root ganglion after gradualelongation of rat sciatic nerves. J. Orthop. Res. 2010, 28, 481-486.
75. Davies, S.L.; Loescher, A.R.; Clayton, N.M.; Bountra, C.; Robinson, P.P.; Boissonade, F.M. Changes in sodium channel expression following trigeminal nerve injury. Exp. Neurol. 2006, 202, 207-216. (Pubitemid 44344262)
76. Nassar, M.A.; Baker, M.D.; Levato, A.; Ingram, R.; Mallucci, G.; McMahon, S.B.; Wood, J.N. Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol. Pain 2006, 2, doi:10.1186/1744-8069-2-33.
77. Caldwell, J.H.; Schaller, K.L.; Lasher, R.S.; Peles, E.; Levinson, S.R. Sodium channel Nav1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc. Natl. Acad. Sci. USA 2000, 97, 5616-5620. (Pubitemid 30313767)
78. Tzoumaka, E.; Tischler, A.C.; Sangameswaran, L.; Eglen, R.M.; Hunter, J.C.; Novakovic, S.D. Differential distribution of the tetrodotoxin-sensitive rPN4/NaCh6/Scn8a sodium channel in the nervous system. J. Neurosci. Res. 2000, 60, 37-44. (Pubitemid 30176747)
79. Black, J.A.; Renganathan, M.; Waxman, S.G. Sodium channel Nav1.6 is expressed along nonmyelinated axons and it contributes to conduction. Brain Res. Mol. Brain Res. 2002, 105, 19-28. (Pubitemid 35245608)
80. Persson, A.K.; Black, J.A.; Gasser, A.; Cheng, X.; Fischer, T.Z.; Waxman, S.G. Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals. Mol. Pain 2010, 6, doi:10.1186/1744-8069-6-84.
81. Zhao, P.; Barr, T.P.; Hou, Q.; Dib-Hajj, S.D.; Black, J.A.; Albrecht, P.J.; Petersen, K.; Eisenberg, E.; Wymer, J.P.; Rice, F.L.; Waxman, S.G. Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: Evidence for a role in pain. Pain 2008, 139, 90-105.
82. Kim, C.H.; Oh, Y.; Chung, J.M.; Chung, K. Changes in three subtypes of tetrodotoxin sensitive sodium channel expression in the axotomized dorsal root ganglion in the rat. Neurosci. Lett. 2002, 323, 125-128. (Pubitemid 34310256)
83. Raymond, C.K.; Castle, J.; Garrett-Engele, P.; Armour, C.D.; Kan, Z.; Tsinoremas, N.; Johnson, J.M. Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J. Biol. Chem. 2004, 279, 46234-46241. (Pubitemid 39491618)
84. Persson, A.K.; Thun, J.; Xu, X.J.; Wiesenfeld-Hallin, Z.; Ström, M.; Devor, M.; Lidman, O.; Fried, K. Autotomy behavior correlates with the DRG and spinal expression of sodium channels in inbredmouse strains. Brain Res. 2009, 1285, 1-13.
85. Henry, M.A.; Freking, A.R.; Johnson, L.R.; Levinson, S.R. Sodium channel Nav1.6 accumulates at the site of infraorbital nerve injury. BMC Neurosci. 2007, 8, doi:10.1186/1471-2202-8-56.
86. Sangameswaran, L.; Fish, L.M.; Koch, B.D.; Rabert, D.K.; Delgado, S.G.; Ilnicka, M.; Jakeman, L.B.; Novakovic, S.; Wong, K.; Sze, P.; et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J. Biol. Chem. 1997, 272, 14805-14809.
87. Dib-Hajj, S.D.; Cummins, T.R.; Black, J.A.; Waxman, S.G. From genes to pain: Nav 1.7 and human pain disorders. Trends Neurosci. 2007, 30, 555-563. (Pubitemid 350051424)
88. Dib-Hajj, S.D.; Rush, A.M.; Cummins, T.R.; Hisama, F.M.; Novella, S.; Tyrrell, L.; Marshall, L.; Waxman, S.G. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 2005, 128, 1847-1854. (Pubitemid 41373656)
89. Lee, M.J.; Yu, H.S.; Hsieh, S.T.; Stephenson, D.A.; Lu, C.J.; Yang, C.C. Characterization of a familial case with primary erythromelalgia from Taiwan. J. Neurol. 2007, 254, 210-214.
90. Nilsen, K.B.; Nicholas, A.K.; Woods, C.G.; Mellgren, S.I.; Nebuchennykh, M.; Aasly, J. Two novel SCN9A mutations causing insensitivity to pain. Pain 2009, 143, 155-158.
91. Gould, H.J., 3rd.; England, J.D.; Soignier, R.D.; Nolan, P.; Minor, L.D.; Liu, Z.P.; Levinson, S.R.; Paul, D. Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat. J. Pain 2004, 5, 270-280. (Pubitemid 38859681)
92. Strickland, I.T.; Martindale, J.C.; Woodhams, P.L.; Reeve, A.J.; Chessell, I.P.; McQueen, D.S. Changes in the expression of Nav1.7, Nav1.8 and Nav1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain. Eur. J. Pain 2008, 12, 564-572. (Pubitemid 351615304)
93. Gould, H.J., 3rd.; Gould, T.N.; England, J.D.; Paul, D.; Liu, Z.P.; Levinson, S.R. A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res. 2000, 854, 19-29. (Pubitemid 30067656)
94. Yeomans, D.C.; Levinson, S.R.; Peters, M.C.; Koszowski, A.G.; Tzabazis, A.Z.; Gilly, W.F.; Wilson, S.P. Decrease in inflammatory hyperalgesia by herpes vector-mediated knockdown of Nav1.7 sodium channels in primary afferents. Hum. Gene Ther. 2005, 16, 271-277. (Pubitemid 40344218)
95. Nassar, M.A.; Stirling, L.C.; Forlani, G.; Baker, M.D.; Matthews, E.A.; Dickenson, A.H.; Wood, J.N. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatorypain. Proc. Natl. Acad. Sci. USA 2004, 101, 12706-12711. (Pubitemid 39122087)
96. Nassar, M.A.; Levato, A.; Stirling, L.C.; Wood, J.N. Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol. Pain 2005, 1, doi:10.1186/1744-8069-1-24.
97. Chattopadhyay, M.; Mata, M.; Fink, D.J. Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J. Neurosci. 2008, 28, 6652-6658.
98. Persson, A.K.; Gasser, A.; Black, J.A.; Waxman, S.G. Nav1.7 accumulates and co-localizes with phosphorylated ERK1/2 within transected axons in earlyexperimental neuromas. Exp. Neurol. 2011, 230, 273-279.
99. Kretschmer, T.; Happel, L.T.; England, J.D.; Nguyen, D.H.; Tiel, R.L.; Beuerman, R.W.; Kline, D.G. Accumulation of PN1 and PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry. Acta Neurochir. 2002, 144, 803-810. (Pubitemid 34985275)
100. Luo, S.; Perry, G.M.; Levinson, S.R.; Henry, M.A. Nav1.7 expression is increased in painful human dental pulp. Mol. Pain 2008, 4, doi:10.1186/1744- 8069-4-16.
101. Yiangou, Y.; Facer, P.; Chessell, I.P.; Bountra, C.; Chan, C.; Fertleman, C.; Smith, V.; Anand, P. Voltage-gated ion channel Nav1.7 innervation in patients with idiopathic rectal hypersensitivity and paroxysmal extreme pain disorder (familial rectal pain). Neurosci. Lett. 2007, 427, 77-82. (Pubitemid 47633792)
102. Schwartz, D.M.; Duncan, K.G.; Fields, H.L.; Jones, M.R. Tetrodotoxin: Anesthetic activity in the de-epithelialized cornea. Graefes Arch. Clin. Exp. Ophthalmol. 1998, 236, 790-794. (Pubitemid 28458681)
103. Schwartz, D.M.; Fields, H.L.; Duncan, K.G.; Duncan, J.L.; Jones, M.R. Experimental study of tetrodotoxin, a long-acting topical anesthetic. Am. J. Ophthalmol. 1998, 125, 481-487. (Pubitemid 28236915)
104. Xie, W.; Strong, J.A.; Meij, J.T.; Zhang, J.M.; Yu, L. Neuropathic pain: Early spontaneous afferent activity is the trigger. Pain 2005, 116, 243-256. (Pubitemid 40957128)
105. Houck, C.S.; Khodorova, A.; Reale, A.M.; Strichartz, G.R.; Davar, G. Sensory fibers resistant to the actions of tetrodotoxin mediate nocifensive responses to local administration of endothelin-1 in rats. Pain 2004, 110, 719-726. (Pubitemid 39036804)
106. Barnet, C.S.; Tse, J.Y.; Kohane, D.S. Site 1 sodium channel blockers prolong the duration of sciatic nerve blockade from tricyclic antidepressants. Pain 2004, 110, 432-438. (Pubitemid 38953309)
107. Marcil, J.; Walczak, J.S.; Guindon, J.; Ngoc, A.H.; Lu, S.; Beaulieu, P. Antinociceptive effects of tetrodotoxin (TTX) in rodents. Br. J. Anaesth. 2006, 96, 761-768. (Pubitemid 43786693)
108. Nieto, F.R.; Entrena, J.M.; Cendán, C.M.; Pozo, E.D.; Vela, J.M.; Baeyens, J.M. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain 2008, 137, 520-531. (Pubitemid 351970170)
109. Entrena, J.M.; Cobos, E.J.; Nieto, F.R.; Cendán, C.M.; Gris, G.; Del Pozo, E.; Zamanillo, D.; Baeyens, J.M. Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain 2009, 143, 252-261.
110. Kayser, V.; Viguier, F.; Ioannidi, M.; Bernard, J.F.; Latrémolière, A.; Michot, B.; Vela, J.M.; Buschmann, H.; Hamon, M.; Bourgoin, S. Differential anti-neuropathic pain effects of tetrodotoxin in sciatic nerve- versus infraorbital nerve-ligated rats-behavioral, pharmacological and immunohistochemical investigations. Neuropharmacology 2010, 58, 474-487.
111. Iwamoto, T.; Takasugi, Y.; Higashino, H.; Ito, H.; Koga, Y.; Nakao, S. Antinociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation. J. Anesth. 2011, 25, 78-86.
112. Le Bars, D.; Gozariu, M.; Cadden, S.W. Animal models of nociception. Pharmacol. Rev. 2001, 53, 597-652. (Pubitemid 33136239)
113. Beloeil, H.; Ababneh, Z.; Chung, R.; Zurakowski, D.; Mulkern, R.V.; Berde, C.B. Effects of bupivacaine and tetrodotoxin on carrageenan-induced hind paw inflammation in rats (Part 1): Hyperalgesia, edema, and systemic cytokines. Anesthesiology 2006, 105, 128-138. (Pubitemid 44305201)
114. Alguacil, L.F.; Pérez-García, C.; Salas, E.; González-Martín, C.; Castillo, C.; Polanco, M.J.; Herradón, G.; Morales, L. Subcutaneous tetrodotoxin and inflammatory pain. Br. J. Anaesth. 2008, 100, 729-730. (Pubitemid 351774370)
115. Craner, M.J.; Damarjian, T.G.; Liu, S; Hains, B.C.; Lo, A.C.; Black, J.A.; Newcombe, J.; Cuzner, M.L.; Waxman, S.G. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 2005, 49, 220-229. (Pubitemid 40188501)
116. Lyu, Y.S.; Park, S.K.; Chung, K.; Chung, J.M. Low dose of tetrodotoxin reduces neuropathic pain behaviors in an animal model. Brain Res. 2000, 871, 98-103. (Pubitemid 30406873)
117. Chen, J.J.; Lue, J.H.; Lin, L.H.; Huang, C.T.; Chiang, R.P.; Chen, C.L.; Tsai, Y.J. Effects of pre-emptive drug treatment on astrocyte activation in the cuneate nucleus following rat median nerve injury. Pain 2010, 148, 158-166.
118. Nozaki-Taguchi, N.; Chaplan, S.R.; Higuera, E.S.; Ajakwe, R.C.; Yaksh, T.L. Vincristine-induced allodynia in the rat. Pain 2001, 93, 69-76. (Pubitemid 32530844)
119. Cavaletti, G.; Marmiroli, P. Chemotherapy-induced peripheral neurotoxicity. Nat. Rev. Neurol. 2010, 6, 657-666.
120. Klein, T.; Magerl, W.; Rolke, R.; Treede, R.D. Human surrogate models of neuropathic pain. Pain 2005, 115, 227-233.
121. Xie, W.; Strong, J.A.; Zhang, J.M. Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models. Neuroscience 2009, 160, 847-857.
122. Cummins, T.R.; Black, J.A.; Dib-Hajj, S.D.; Waxman, S.G. Glial-derived neurotrophic factor upregulates expression of functional SNS and NaN sodium channels and their currents in axotomized dorsal root ganglion neurons. J. Neurosci. 2000, 20, 8754-8761.
123. Matzner, O.; Devor, M. Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+ channels. J. Neurophysiol. 1994, 72, 349-359. (Pubitemid 24233656)
124. Omana-Zapata, I.; Khabbaz, M.A.; Hunter, J.C.; Clarke, D.E.; Bley, K.R. Tetrodotoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons. Pain 1997, 72, 41-49. (Pubitemid 27321900)
125. Amir, R.; Michaelis, M.; Devor, M. Membrane potential oscillations in dorsal root ganglion neurons: Role in normal electrogenesis and neuropathic pain. J. Neurosci. 1999, 19, 8589-8596. (Pubitemid 30226776)
126. Liu, X.; Zhou, J.L.; Chung, K.; Chung, J.M. Ion channels associated with the ectopic discharges generated after segmental spinal nerve injury in the rat. Brain Res. 2001, 900, 119-127. (Pubitemid 32452271)
127. Hagen, N.A.; Fisher, K.M.; Lapointe, B.; du Souich, P.; Chary, S.; Moulin, D.; Sellers, E.; Ngoc, A.H.; Canadian Tetrodotoxin Study Group. An open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related pain. J. Pain Symptom Manag. 2007, 34, 171-182.
128. Hagen, N.A.; du Souich, P.; Lapointe, B.; Ong-Lam, M.; Dubuc, B.; Walde, D.; Love, R.; Ngoc, A.H.; Canadian Tetrodotoxin Study Group. Tetrodotoxin for moderate to severe cancer pain: A randomized, double blind, parallel design multicenter study. J. Pain Symptom Manag. 2008, 35, 420-429.
129. Hagen, N.A.; Lapointe, B.; Ong-Lam, M.; Dubuc, B.; Walde, D.; Gagnon, B.; Love, R.; Goel, R.; Hawley, P.; Ngoc, A.H.; du Souich, P. A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain. Curr. Oncol. 2011, 18, 109-116.